Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
451
archived clinical trials in
Rheumatology

Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated:  9/7/2017
Shrock Orthopedic Research, LLC
mi
from
Fort Lauderdale, FL
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated: 9/7/2017
Shrock Orthopedic Research, LLC
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated:  9/7/2017
Jewett Orthopedic Clinic
mi
from
Orlando, FL
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated: 9/7/2017
Jewett Orthopedic Clinic
mi
from
Orlando, FL
Click here to add this to my saved trials
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated:  9/7/2017
Clinical Research of West Florida, Inc.
mi
from
Tampa, FL
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated: 9/7/2017
Clinical Research of West Florida, Inc.
mi
from
Tampa, FL
Click here to add this to my saved trials
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated:  9/7/2017
Non-Surgical Orthopedics, P.C. / Georgia Institute for Clinical Research, LLC
mi
from
Marietta, GA
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated: 9/7/2017
Non-Surgical Orthopedics, P.C. / Georgia Institute for Clinical Research, LLC
mi
from
Marietta, GA
Click here to add this to my saved trials
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated:  9/7/2017
Injury Care Medical Center
mi
from
Boise, ID
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated: 9/7/2017
Injury Care Medical Center
mi
from
Boise, ID
Click here to add this to my saved trials
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated:  9/7/2017
Rockford Orthopedics Associates
mi
from
Rockford, IL
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated: 9/7/2017
Rockford Orthopedics Associates
mi
from
Rockford, IL
Click here to add this to my saved trials
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated:  9/7/2017
Rockford Orthopedic Associates, LTD
mi
from
Rockford, IL
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated: 9/7/2017
Rockford Orthopedic Associates, LTD
mi
from
Rockford, IL
Click here to add this to my saved trials
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated:  9/7/2017
The Indiana Hand to Shoulder Center
mi
from
Indianapolis, IN
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated: 9/7/2017
The Indiana Hand to Shoulder Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated:  9/7/2017
PRN of Kansas
mi
from
Wichita, KA
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated: 9/7/2017
PRN of Kansas
mi
from
Wichita, KA
Click here to add this to my saved trials
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated:  9/7/2017
Central Kentucky Research Associates, Inc.
mi
from
Lexington, KY
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated: 9/7/2017
Central Kentucky Research Associates, Inc.
mi
from
Lexington, KY
Click here to add this to my saved trials
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated:  9/7/2017
Bone and Joint Clinic
mi
from
Gretna, LA
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated: 9/7/2017
Bone and Joint Clinic
mi
from
Gretna, LA
Click here to add this to my saved trials
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated:  9/7/2017
MedPharmics, LLC.
mi
from
Metairie, LA
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated: 9/7/2017
MedPharmics, LLC.
mi
from
Metairie, LA
Click here to add this to my saved trials
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated:  9/7/2017
Arthritis and Rheumatism Associates, PC
mi
from
Wheaton, MD
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated: 9/7/2017
Arthritis and Rheumatism Associates, PC
mi
from
Wheaton, MD
Click here to add this to my saved trials
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated:  9/7/2017
Great Falls Clinic
mi
from
Great Falls, MT
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated: 9/7/2017
Great Falls Clinic
mi
from
Great Falls, MT
Click here to add this to my saved trials
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated:  9/7/2017
Nevada Orthopedic and Spine Center
mi
from
Las Vegas, NV
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated: 9/7/2017
Nevada Orthopedic and Spine Center
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated:  9/7/2017
Stony Brook University Medical Center (SUNY)
mi
from
Stony Brook, NY
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated: 9/7/2017
Stony Brook University Medical Center (SUNY)
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated:  9/7/2017
Triangle Orthopedic Associates, P.A.
mi
from
Durham, NC
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated: 9/7/2017
Triangle Orthopedic Associates, P.A.
mi
from
Durham, NC
Click here to add this to my saved trials
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated:  9/7/2017
Wake Research Associates, LLC
mi
from
Raleigh, NC
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated: 9/7/2017
Wake Research Associates, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated:  9/7/2017
The Neuromusculoskeletal Center of the Cascades d.b.a. The Center
mi
from
Bend, OR
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated: 9/7/2017
The Neuromusculoskeletal Center of the Cascades d.b.a. The Center
mi
from
Bend, OR
Click here to add this to my saved trials
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated:  9/7/2017
Blair Orthopedic Associates, Inc.
mi
from
Altoona, PA
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated: 9/7/2017
Blair Orthopedic Associates, Inc.
mi
from
Altoona, PA
Click here to add this to my saved trials
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated:  9/7/2017
University of Pennsylvania Penn Orthopaedics
mi
from
Philadelphia, PA
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated: 9/7/2017
University of Pennsylvania Penn Orthopaedics
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated:  9/7/2017
Texas Orthopedic Specialist
mi
from
Bedford, TX
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated: 9/7/2017
Texas Orthopedic Specialist
mi
from
Bedford, TX
Click here to add this to my saved trials
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated:  9/7/2017
Centex Studies Inc
mi
from
Houston, TX
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated: 9/7/2017
Centex Studies Inc
mi
from
Houston, TX
Click here to add this to my saved trials
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated:  9/7/2017
Commonwealth Orthopaedics & Rehabilitation
mi
from
Arlington, VA
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated: 9/7/2017
Commonwealth Orthopaedics & Rehabilitation
mi
from
Arlington, VA
Click here to add this to my saved trials
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated:  9/7/2017
Danville Orthopedic Clinic, Inc.
mi
from
Danville, VA
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated: 9/7/2017
Danville Orthopedic Clinic, Inc.
mi
from
Danville, VA
Click here to add this to my saved trials
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated:  9/7/2017
Temecula Rheumatology & Internal Medicine
mi
from
Murrieta, CA
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated: 9/7/2017
Temecula Rheumatology & Internal Medicine
mi
from
Murrieta, CA
Click here to add this to my saved trials
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated:  9/7/2017
Sports Medicine Professionals
mi
from
Richmond,
Clinical Study for the Treatment of Adhesive Capsulitis of the Shoulder
A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of AA4500 for the Treatment of Adhesive Capsulitis of the Shoulder
Status: Enrolling
Updated: 9/7/2017
Sports Medicine Professionals
mi
from
Richmond,
Click here to add this to my saved trials
Anti-CD20 Antibody Therapy for Sjogren's Syndrome
An Open-Label, One Arm, Phase I Safety Study of Anti-CD20 Antibody (Rituximab, Rituxan) Therapy in the Treatment of Primary Sjogren's Syndrome
Status: Enrolling
Updated:  10/18/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Anti-CD20 Antibody Therapy for Sjogren's Syndrome
An Open-Label, One Arm, Phase I Safety Study of Anti-CD20 Antibody (Rituximab, Rituxan) Therapy in the Treatment of Primary Sjogren's Syndrome
Status: Enrolling
Updated: 10/18/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Anti-CD20 Antibody Therapy for Sjogren's Syndrome
An Open-Label, One Arm, Phase I Safety Study of Anti-CD20 Antibody (Rituximab, Rituxan) Therapy in the Treatment of Primary Sjogren's Syndrome
Status: Enrolling
Updated:  10/18/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Anti-CD20 Antibody Therapy for Sjogren's Syndrome
An Open-Label, One Arm, Phase I Safety Study of Anti-CD20 Antibody (Rituximab, Rituxan) Therapy in the Treatment of Primary Sjogren's Syndrome
Status: Enrolling
Updated: 10/18/2017
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Birmingham, AL
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Phoenix, AZ
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Sacramento, CA
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
San Diego, CA
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Brandon, FL
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Brandon, FL
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
DeLand, FL
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
DeLand, FL
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Lakeland, FL
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Lakeland, FL
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Ocala, FL
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Ocala, FL
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Orlando, FL
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Tampa, FL
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Tampa, FL
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
West Palm Beach, FL
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Columbus, GA
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Columbus, GA
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Smyrna, GA
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Smyrna, GA
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Evansville, IN
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
North Dartmouth, MA
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
North Dartmouth, MA
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Ann Arbor, MI
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Jackson, MS
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Jackson, MS
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Williamsville, NY
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Williamsville, NY
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Cincinnati, OH
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated:  12/8/2017
Clinical Research Facility
mi
from
Columbus, OH
A Study to Evaluate eFFIcacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime in Patients With fibRoMyalgia
A Phase 3, Double-Blind, Randomized, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TNX-102 SL Tablets Taken Daily at Bedtime in Patients With Fibromyalgia
Status: Enrolling
Updated: 12/8/2017
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials